» Articles » PMID: 30099094

Targeting Neurodegeneration to Prevent Post-traumatic Epilepsy

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2018 Aug 13
PMID 30099094
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In the quest for developing new therapeutic targets for post-traumatic epilepsies (PTE), identifying mechanisms relevant to development and progression of disease is critical. A growing body of literature suggests involvement of neurodegenerative mechanisms in the pathophysiology of acquired epilepsies, including following traumatic brain injury (TBI). In this review, we discuss the potential of some of these mechanisms to be targets for the development of a therapy against PTE.

Citing Articles

Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures.

Rodriguez S, Sharma S, Tiarks G, Peterson Z, Jackson K, Thedens D Sci Rep. 2024; 14(1):13507.

PMID: 38867062 PMC: 11169394. DOI: 10.1038/s41598-024-63942-8.


Posttraumatic Epilepsy and Dementia Risk.

Schneider A, Law C, Gottesman R, Krauss G, Huang J, Kucharska-Newton A JAMA Neurol. 2024; .

PMID: 38407883 PMC: 10897826. DOI: 10.1001/jamaneurol.2024.0010.


Levetiracetam Pharmacokinetics and Brain Uptake in a Lateral Fluid Percussion Injury Rat Model.

Coles L, Saletti P, Lisgaras C, Casillas-Espinosa P, Liu W, Li Q J Pharmacol Exp Ther. 2023; 386(2):259-265.

PMID: 37316328 PMC: 10353071. DOI: 10.1124/jpet.122.001377.


Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study.

Saletti P, Casillas-Espinosa P, Lisgaras C, Bi Mowrey W, Li Q, Liu W J Neurotrauma. 2023; 41(1-2):222-243.

PMID: 36950806 PMC: 11079442. DOI: 10.1089/neu.2022.0219.


Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms.

Hwang K, Vaknalli R, Addo-Osafo K, Vicente M, Vossel K Front Aging Neurosci. 2022; 14:903973.

PMID: 35923547 PMC: 9340804. DOI: 10.3389/fnagi.2022.903973.


References
1.
Lozano D, Gonzales-Portillo G, Acosta S, De la Pena I, Tajiri N, Kaneko Y . Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat. 2015; 11:97-106. PMC: 4295534. DOI: 10.2147/NDT.S65815. View

2.
Corrigan F, Pham C, Vink R, Blumbergs P, Masters C, Van Den Heuvel C . The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res. 2011; 1378:137-43. DOI: 10.1016/j.brainres.2010.12.077. View

3.
Jones N, Nguyen T, Corcoran N, Velakoulis D, Chen T, Grundy R . Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol Dis. 2011; 45(3):897-901. DOI: 10.1016/j.nbd.2011.12.005. View

4.
McKee A, Stern R, Nowinski C, Stein T, Alvarez V, Daneshvar D . The spectrum of disease in chronic traumatic encephalopathy. Brain. 2012; 136(Pt 1):43-64. PMC: 3624697. DOI: 10.1093/brain/aws307. View

5.
Chen L, Wang Y, Tseng G . Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons. J Neurotrauma. 2010; 27(9):1657-69. DOI: 10.1089/neu.2010.1308. View